Trademark: 90898397
Word
RINUAGENE
Status Date
Wednesday, May 8, 2024
Filing Date
Tuesday, August 24, 2021
Published for Opposition
Tuesday, August 23, 2022
1 Biochemicals, namely, proteins, protein-encoding nucleic acids, polypeptide-encoding nucleic acids and polypeptides for use in vivo, ex vivo, on vivo or in vitro scientific research and medical research, and for use in the manufacture of food or nutritional supplements; biochemicals, namely, proteins, protein-encoding nucleic acids, polypeptide-encoding nucleic acids and polypeptides for use in the manufacture of pharmaceuticals for treating rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, metabolic disorders, infectious disorders and reproductive disorders; active chemical ingredients for use in manufacture of biotherapeutics, biosimilars and therapeutics products for treating infectious diseases and cancer; chemicals for use in biotherapeutics, biosimilars and therapeutics product development and manufacturing processes; adjuvants for use in manufacture of vaccines; reagents for testing sterility of pharmaceuticals; protein arrays and nucleotide arrays for scientific and medical laboratory use for scientific and medical research; nucleic acids, proteins and peptides for laboratory use; diagnostic preparations for clinical or medical laboratory use; diagnostic preparations for scientific or research use other than for medical purposes
Aug 27, 2021
New Application Entered
Oct 10, 2021
New Application Office Supplied Data Entered
May 26, 2022
Assigned To Examiner
Jun 9, 2022
Non-Final Action Written
Jun 9, 2022
Non-Final Action E-Mailed
Jun 9, 2022
Notification Of Non-Final Action E-Mailed
Jul 15, 2022
Teas Withdrawal Of Attorney Received
Jul 15, 2022
Withdrawal Of Attorney Granted
Jul 15, 2022
Teas Response To Office Action Received
Jul 15, 2022
Teas Response To Office Action Received
Jul 15, 2022
Correspondence Received In Law Office
Jul 15, 2022
Teas/Email Correspondence Entered
Jul 18, 2022
Approved For Pub - Principal Register
Aug 3, 2022
Notification Of Notice Of Publication E-Mailed
Aug 23, 2022
Published For Opposition
Aug 23, 2022
Official Gazette Publication Confirmation E-Mailed
Oct 18, 2022
Noa E-Mailed - Sou Required From Applicant
Mar 20, 2023
Sou Teas Extension Received
Mar 20, 2023
Sou Extension 1 Filed
Mar 20, 2023
Sou Extension 1 Granted
Mar 20, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Mar 20, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Mar 20, 2023
Teas Change Of Correspondence Received
Mar 22, 2023
Notice Of Approval Of Extension Request E-Mailed
Apr 17, 2023
Teas Change Of Owner Address Received
Apr 17, 2023
Teas Change Of Correspondence Received
Apr 17, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Oct 4, 2023
Assigned To Examiner
Oct 11, 2023
Sou Teas Extension Received
Oct 11, 2023
Sou Extension 2 Filed
Oct 11, 2023
Sou Extension 2 Granted
Oct 13, 2023
Notice Of Approval Of Extension Request E-Mailed
Apr 12, 2024
Sou Extension 3 Filed
Apr 12, 2024
Divisional Request Received
Apr 12, 2024
Sou Teas Extension Received
Apr 12, 2024
Teas Request To Divide Received
Apr 23, 2024
Case Assigned To Intent To Use Paralegal
May 8, 2024
Sou Extension 3 Granted
May 8, 2024
Divisional Processing Complete
May 9, 2024
Corrected Noa E-Mailed
May 9, 2024
Notice Of Approval Of Extension Request E-Mailed
Trademark Alertz updated from USPTO on 2030-01-24
